Product Images Ramipril

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Ramipril NDC 51407-708 by Gsms, Incorporated, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemstructure - chemstruc

chemstructure - chemstruc

containerlabel10 - containerlabel10

containerlabel10 - containerlabel10

This text provides information about a medication in capsule form containing Ramipril, USP 10 mg. It includes dosage and administration details, a warning to keep out of reach of children, storage instructions, and manufacturing details. Marketed by GSMS, Incorporated and manufactured by CorePharma, LLC. The medication comes in a pack of 100 capsules.*

containerlabel2point5 - containerlabel2point5

containerlabel2point5 - containerlabel2point5

This is information related to Ramipril capsules, USP containing 2.5 mg of Ramipril per capsule. The prescription medication comes in a container with 100 capsules, and the dosage and administration details can be found in the package insert. It is important to keep this medication away from children and store it at a temperature between 20° to 25°C (68 to 77°F). The capsules should be dispensed in tight, light-resistant, child-resistant containers by pharmacists. The product is marketed by GSMS, Incorporated in Camarillo, California, and manufactured by CorePharma, LLC in Middlesex, New Jersey.*

containerlabel5 - containerlabel5

containerlabel5 - containerlabel5

This text is a product label for Ramipril Capsules, which contains 5 mg of Ramipril. It includes information on dosage, administration, warnings, storage instructions, and details of the manufacturer and marketer. The product is marketed by GSMS, Incorporated and manufactured by CorePharma, LLC.*

figure1 - figure1

figure1 - figure1

This is a chart showing the proportion of patients over 1000 days of follow-up. The proportions are given for different time intervals.*

figure2 - figure2

figure2 - figure2

This is a statistical data table showing the incidence of different outcomes in patients receiving placebo. The outcomes include cardiovascular disease, diabetes, age groups, gender, hypertension, history of coronary artery disease, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The table also includes the number of patients in each category and a column for the relative risk in the Ramipril group with a 95% confidence interval.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.